205 related articles for article (PubMed ID: 28159174)
21. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.
Chen CY; Chen KY; Hsueh PR; Yang PC
J Formos Med Assoc; 2006 Mar; 105(3):256-62. PubMed ID: 16520845
[TBL] [Abstract][Full Text] [Related]
22. [Antibiotic treatment for legionellosis].
Calbo E; Garau J
Enferm Infecc Microbiol Clin; 2006; 24(6):357-9. PubMed ID: 16792935
[No Abstract] [Full Text] [Related]
23. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy.
Rello J; Gattarello S; Souto J; Sole-Violan J; Valles J; Peredo R; Zaragoza R; Vidaur L; Parra A; Roig J;
Med Intensiva; 2013; 37(5):320-6. PubMed ID: 22854618
[TBL] [Abstract][Full Text] [Related]
24. [Legionelloses].
Widmer AF
Ther Umsch; 2001 Oct; 58(10):592-8. PubMed ID: 11695089
[TBL] [Abstract][Full Text] [Related]
25. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
[TBL] [Abstract][Full Text] [Related]
26. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia: our cup runneth over?
Yu VL; Vergis EN
Chest; 1998 May; 113(5):1158-9. PubMed ID: 9596286
[No Abstract] [Full Text] [Related]
27. Legionnaires disease and the updated IDSA guidelines for community-acquired pneumonia.
Yu VL; Ramirez J; Roig J; Sabria M
Clin Infect Dis; 2004 Dec; 39(11):1734-7; author reply 1737-8. PubMed ID: 15578385
[No Abstract] [Full Text] [Related]
28. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
[TBL] [Abstract][Full Text] [Related]
29. Problem pathogens: paediatric legionellosis--implications for improved diagnosis.
Greenberg D; Chiou CC; Famigilleti R; Lee TC; Yu VL
Lancet Infect Dis; 2006 Aug; 6(8):529-35. PubMed ID: 16870531
[TBL] [Abstract][Full Text] [Related]
30. Prescription of macrolides in community-acquired pneumonia: science or art?
Rello J
Chest; 1998 May; 113(5):1155-8. PubMed ID: 9596285
[No Abstract] [Full Text] [Related]
31. Legionella species community-acquired pneumonia.
Kane GC
Chest; 1997 Jan; 111(1):254. PubMed ID: 8996030
[No Abstract] [Full Text] [Related]
32. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
33. [A case of legionnaire's disease due to Legionella pneumophila serogroup 6].
Takamori M; Nakano K; Ubukata H; Suzuki S; Funaki N; Oyama K; Shimada K
Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):1127-9. PubMed ID: 9702025
[No Abstract] [Full Text] [Related]
34. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic stewardship in community-acquired pneumonia.
Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
[TBL] [Abstract][Full Text] [Related]
36. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
[TBL] [Abstract][Full Text] [Related]
37. Legionnaires' disease and pneumonia. Beware the temptation to underestimate this "exotic" cause of infection.
Akbas E; Yu VL
Postgrad Med; 2001 May; 109(5):135-8, 141-2, 147. PubMed ID: 11381664
[TBL] [Abstract][Full Text] [Related]
38. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias].
Rodríguez de Castro F
Arch Bronconeumol; 1999 Jun; 35(6):253-6. PubMed ID: 10410203
[No Abstract] [Full Text] [Related]
39. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
40. Impact of positive microbiological diagnosis on management and prognosis of severe community-acquired pneumonia.
Leroy O; d'Escrivan T; Georges H; Alfandari S
Chest; 2003 Sep; 124(3):1179-80. PubMed ID: 12970059
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
